Tuesday, June 14, 2016 10:08:43 AM
Robert H. Pierce, MD, Chief Scientific Officer, will present a lecture entitled: "Intratumoral IL-12 Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)" during the "Updates on Immunotherapy Trials in HPV-HNSCC" session at the EUROGIN 2016 Conference on June 16 at 4:15 PM CEST at the Salzburg Congress in Salzburg, Austria.
This conference focuses on human papillomavirus infection and related cancers and fosters multidisciplinary interactions that are vital to making critical discoveries. The conference is aimed at developing a full review of current scientific developments in the field of cancer and human papillomavirus related diseases, raising the public health profile, and increasing the need for responsible health services. The program also encompasses state-of-the art science on ano-genital and head and neck cancer and provides forums to share expertise and learn from the leading experts in these fields. For more information, please visit: http://www.eurogin.com/2016/.
Maybe this will increase the volume and interest.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM